Results 201 to 210 of about 26,261 (211)

Glucagon-Like Peptide 1 Receptor Agonist

openaire   +1 more source

The effect of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats

EBioMedicine
Kirsten Raun, Wouter Hogendorf
exaly  

Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis

Journal of Hepatology
Naim Alkhouri, Daniel Mazo, Jorn M Schattenberg   +2 more
exaly  

Endoscopy and anesthesia outcomes associated with glucagon-like peptide-1 receptor agonist use in patients undergoing outpatient upper endoscopy

Gastrointestinal Endoscopy
Inuk Zandvakili, Ahmed Chatila
exaly  

Glucagon-like peptide-1 receptor agonists and aspiration risk

BMJ
Daniel I, McIsaac, Gregory L, Bryson
openaire   +2 more sources

Glucagon-like Peptide-1 Receptor Agonist Use in Hospital: A Multicentre Observational Study

Canadian Journal of Diabetes
Daniel Drucker, Michael Fralick
exaly  

Glucagon-like peptide 1 receptor agonists and uses thereof

2019
WEI YANG, OKAMOTO HARUKA, GROMADA JESPER, DAVIS SAMUEL, MURPHY ANDREW   +4 more
openaire   +6 more sources

Association between glucagon‐like peptide‐1 receptor agonist use and peri‐operative pulmonary aspiration: a systematic review and meta‐analysis

Anaesthesia
Cade Shadbolt
exaly  

Weighing in on glucagon-like peptide-1 receptor agonists in dermatology

Journal of the American Academy of Dermatology
openaire   +2 more sources

Obesity, diabetes and glucagon-like peptide-1 receptor agonists

Archives of Disease in Childhood
openaire   +2 more sources